[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fhuC6ErWOUzw0RahDWS92sea1d3gYqM64ogYUP7Qu2nc":8,"$fJ-EWH0jK4g6zTVSQzN8yKj0uSyTURwTBq_Fy10sPd98":55,"$fbL5LMzOsbHBTm30znclUYD2mm3jsYPjGXh1SYPRrUN4":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66656,867470,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//tmm0MeOlIZ7EjanP8gTNEI0K2urhqPtc.png","李蓉","山西白求恩医院","肿瘤科","副主任医师",10,0,"浸润性导管癌：您需要了解的重要信息","","https://ystcdn.venuertc.com/venue/AI/b670e87b-01ed-4bde-ba08-51d31be9baec.jpg","\u003Cdiv id=\"material_title\" class=\"indep-title\">浸润性导管癌：您需要了解的重要信息\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #e6eefe 0%, #f9fbff 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 什么是浸润性导管癌？\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    其实，身边很多朋友一提到乳腺肿瘤，头脑里的画面都是“长了个包块”或者“摸到了硬结”。浸润性导管癌（也常叫侵袭性乳腺癌）是临床上最常见的乳腺恶性肿瘤类型。说起来，它源自乳腺里的小管道——导管——这里原本是乳汁流动的“通道”，可一旦通道里的细胞发生异常增生，失控，就有可能走向癌变。\u003Cbr>\u003Cbr>\n    早期的时候很多人毫无察觉，因为肿瘤往往很小，也不痛不痒——像家里水管里头出现微小裂缝。但一旦癌细胞突破“管道”，向外侵袭，就可能扩散到乳腺周边组织甚至远处器官。值得关注的是，浸润性导管癌并不局限于某个年龄阶段，虽然以40岁以上女性居多，但年轻女性也有患病的风险。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #eaffe9 0%, #f7fbf9 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 浸润性导管癌的主要症状是什么？\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    很多时候，身体出现的变化最初并不明显——就像偶尔出现的小麻烦，不用太紧张，但也别忽视。主要症状可以分为两类：\u003Cbr>\u003Cbr>\n    \u003Cstrong>1. 轻微或早期症状\u003C/strong>\u003Cbr>\n    有时会摸到乳腺里有个小硬块，摸起来像圆珠或豆子，也可能是偶尔间断性的乳头分泌物。这类症状不易察觉，尤其是阻塞性导管癌早期，只有少数人感觉乳腺局部有轻微胀痛。\u003Cbr>\u003Cbr>\n    \u003Cstrong>2. 明显或持续症状\u003C/strong>\u003Cbr>\n    如果肿块逐渐增大、变硬，并出现乳头分泌物颜色异常（比如带血）、乳腺皮肤凹陷、红肿或疼痛加重，甚至乳腺形态发生变化，这时就要格外小心了。案例中那位64岁的女性患者，最初只是感到左侧胸部有点胀，后期才发现肿块变大，而且伴随胸壁疼痛。\u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:21px;\">🩺\u003C/span> 遇到这些持续或反复加重的症状，请及时到医院做专业检查。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #fff1ea 0%, #f9f7f7 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 浸润性导管癌的致病机制与风险因素\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    说起来，癌症像“不速之客”，常常与生活习惯、遗传和环境因素相关。浸润性导管癌的发生原因有以下几个方面：\u003Cbr>\u003Cbr>\n    \u003Cstrong>遗传背景\u003C/strong> 有家族乳腺癌史的人，尤其是直系亲属出现过乳腺肿瘤，发病概率会显著升高。研究（Mavaddat et al., 2019）指出，BRCA1或BRCA2等基因突变，乳腺癌风险比普通人群高近10倍。\u003Cbr>\u003Cbr>\n    \u003Cstrong>内分泌因素\u003C/strong> 长期雌激素水平偏高，比如女性晚婚、晚育或者未育，初潮早、绝经晚，都会提高乳腺细胞增生机会——这些细胞一旦积累遗传损伤，就容易癌变。\u003Cbr>\u003Cbr>\n    \u003Cstrong>环境与生活习惯\u003C/strong> 吸烟、饮酒、长期高脂饮食等会损伤乳腺组织；肥胖和缺乏运动也可能增加风险。世界卫生组织报告提出，肥胖与乳腺癌之间存在明确相关性（WHO, 2022）。另外，长期暴露于辐射或有毒化学物质，乳腺癌风险都会升高。\u003Cbr>\u003Cbr>\n    \u003Cstrong>年龄因素\u003C/strong> 50岁以后发病率显著升高，不过年轻人也不能掉以轻心。\n    \u003Cbr>\u003Cbr>\n    🧬 这些风险因素不是绝对的，只是提醒我们关注自己的健康变化。\u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:18px;\">【参考文献】\u003C/span>\u003Cbr>\n    Mavaddat, N., et al. (2019). \"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).\" Cancer Epidemiology Biomarkers & Prevention, 28(10), 1656-1663.\u003Cbr>\n    World Health Organization. (2022). \"Breast cancer factsheet.\" Retrieved from https://www.who.int/news-room/fact-sheets/detail/breast-cancer\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #eaf6fa 0%, #f7fbfd 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 如何诊断浸润性导管癌？\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    如果发现乳腺有异常变化，最快捷有效的方法是进行乳腺影像学检查。常用的有以下几种：\u003Cbr>\u003Cbr>\n    \u003Cstrong>1. 乳腺X线摄影（钼靶）\u003C/strong>\u003Cbr>\n    这种检查方式可以发现微小钙化点和结构异常，为乳腺肿瘤的筛查提供重要信息。\u003Cbr>\u003Cbr>\n    \u003Cstrong>2. 乳腺超声检查\u003C/strong>\u003Cbr>\n    超声对于发现乳腺肿块、区分囊实性病变特别有帮助，尤其适用于乳腺组织致密的年轻女性。\u003Cbr>\u003Cbr>\n    \u003Cstrong>3. 病理学分析\u003C/strong>\u003Cbr>\n    如果影像学发现可疑异常，医生通常会建议穿刺或切取组织送检。病理诊断可以进一步确认癌症类型和分级，对后续治疗方案制定十分关键。\u003Cbr>\u003Cbr>\n    临床上还会结合血液检测、肿瘤标志物检查以及必要的全身影像学评估（如CT或MRI扫描）来判断有没有远处转移。\u003Cbr>\u003Cbr>\n    ⚗️ 选择正规医疗机构、遵医嘱完成检查，是科学诊断癌症的前提。\n    \u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:18px;\">【参考文献】\u003C/span>\u003Cbr>\n    Monticciolo, D. L., et al. (2018). \"Breast cancer screening: A summary of evidence.\" Journal of the American College of Radiology, 15(3), 408-415.\u003Cbr>\n    American Cancer Society. (2023). \"Breast Cancer Early Detection and Diagnosis.\" \u003Ca href=\"https://www.cancer.org/cancer/types/breast-cancer/detection-diagnosis-staging.html\" target=\"_blank\" style=\"color:#4A90E2;\">ACS官网\u003C/a>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #fffaf3 0%, #fdfaf9 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 浸润性导管癌的治疗选择及其优点\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    乳腺癌的标准治疗并不是“一刀切”，而是根据每个人的病情量身定制。常见方式包含以下几类：\u003Cbr>\u003Cbr>\n    \u003Cstrong>手术治疗\u003C/strong> 早期乳腺浸润性导管癌，通常首选手术切除病灶；部分患者可保留乳房，通过“乳腺肿块切除术”只去除肿瘤区域，对外观影响较小。\u003Cbr>\u003Cbr>\n    \u003Cstrong>放射治疗\u003C/strong> 手术后局部加放疗，可以有效降低复发的几率，尤其适合组织切缘距肿瘤较近的情况。\u003Cbr>\u003Cbr>\n    \u003Cstrong>化疗与靶向药物\u003C/strong> 有些浸润性导管癌对传统化疗药物敏感，比如紫杉醇联合靶向治疗。案例中的64岁女性，术后复发并出现多处转移，接受了白蛋白紫杉醇与靶向药物的综合方案，配合骨保护治疗和其他辅助药物，整体状态有改善。\u003Cbr>\u003Cbr>\n    \u003Cstrong>内分泌治疗\u003C/strong> 针对雌激素受体阳性的病人，有些药物能够降低复发率和远处转移风险。\u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:21px;\">💊\u003C/span> 综合治疗方案能帮助更多患者获得长期生存和更好的生活质量，不过需要根据个人情况，由肿瘤科医生制定最合适的方案。\n    \u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:18px;\">【参考文献】\u003C/span>\u003Cbr>\n    National Comprehensive Cancer Network. (2023). \"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer.\" NCCN Guidelines.\u003Cbr>\n    Gradishar, W. J., et al. (2022). \"Breast Cancer, Version 4.2022, NCCN Clinical Practice Guidelines in Oncology.\" Journal of the National Comprehensive Cancer Network, 20(7), 691-722.\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #f3fafd 0%, #fcfefe 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 日常生活中如何管理浸润性导管癌？\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    管理癌症不仅靠治疗，更需要生活里的点滴调养。下面这些建议很实用：\u003Cbr>\u003Cbr>\n    \u003Cstrong>高蛋白营养\u003C/strong> \u003Cbr>\n    食用鱼、鸡胸肉、豆制品等高蛋白食品，能帮助术后恢复和抵抗力提升。比如，刚做完化疗的患者，医生会建议多补充蛋白质，搭配时可适当穿插蔬菜，保证维生素和微量元素摄入。\u003Cbr>\u003Cbr>\n    \u003Cstrong>均衡饮食\u003C/strong> \u003Cbr>\n    蔬菜水果丰富的饮食，有助于抗氧化和维持免疫。苹果、菠菜、西兰花等，都可以常做成家常菜。\u003Cbr>\u003Cbr>\n    \u003Cstrong>适度运动\u003C/strong> \u003Cbr>\n    散步、轻量瑜伽，每天活动30分钟，有益减轻术后乏力和焦虑感。不过，如果有胸水、呼吸困难等症状，应根据医生指导调整活动量。\u003Cbr>\u003Cbr>\n    \u003Cstrong>规律检查\u003C/strong> \u003Cbr>\n    癌症诊疗后要遵照医生的随访时间表，比如血常规、肝功能、白蛋白复查。案例中那位患者出院后安排了3天内复查，后续还要根据化疗周期返院。每个人的检测方案都不同，重点是按时完成就好。\u003Cbr>\u003Cbr>\n    \u003Cstrong>心态调适\u003C/strong> \u003Cbr>\n    保持积极乐观，适当与亲友沟通交流，或寻求心理疏导，对恢复同样重要。\u003Cbr>\u003Cbr>\n    🎗️ 健康的生活方式、科学随访和营养饮食总能帮助我们迈过这道难关，提升生活质量。\n    \u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:18px;\">【参考文献】\u003C/span>\u003Cbr>\n    Demark-Wahnefried, W., et al. (2018). \"Lifestyle interventions and breast cancer prognosis: The role of nutrition and physical activity.\" Annual Review of Nutrition, 38, 1-13.\u003Cbr>\n    American Society of Clinical Oncology. (2023). \"Cancer Nutrition Guidelines.\" Retrieved from https://www.asco.org\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"indep-section\" style=\"background: linear-gradient(90deg, #f7f7fc 0%, #fbfbfe 100%);\">\n  \u003Ch2 class=\"indep-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 浸润性导管癌管理的启发\u003C/h2>\n  \u003Cdiv class=\"indep-content\">\n    了解浸润性导管癌不应该是让人有压力，而是一次对健康的重新认识。无论哪一阶段，发现异常变化、及时做检查、科学治疗和用心生活都是关键。每个人都可以根据实际情况调整自己的管理办法，比如多吃点高蛋白、把身体的小变化放心上，既能早发现、早干预，也能在治疗路上迈得更稳一些。\u003Cbr>\u003Cbr>\n    📚 最后，如果身边亲友有相似的经历，也可以分享这份科普指南，让更多人重视乳腺健康。健康知识，值得在生活中时时温习，但不用过度焦虑。\u003Cbr>\u003Cbr>\n    \u003Cspan style=\"font-size:18px;\">【引用文献总览】\u003C/span>\u003Cbr>\n    Mavaddat, N., et al. (2019). \"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).\" Cancer Epidemiology Biomarkers & Prevention, 28(10), 1656-1663.\u003Cbr>\n    World Health Organization. (2022). \"Breast cancer factsheet.\"\u003Cbr>\n    Monticciolo, D. L., et al. (2018). \"Breast cancer screening: A summary of evidence.\" Journal of the American College of Radiology, 15(3), 408-415.\u003Cbr>\n    National Comprehensive Cancer Network. (2023). \"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer.\"\u003Cbr>\n    Gradishar, W. J., et al. (2022). \"Breast Cancer, Version 4.2022.\" Journal of the National Comprehensive Cancer Network, 20(7), 691-722.\u003Cbr>\n    Demark-Wahnefried, W., et al. (2018). \"Lifestyle interventions and breast cancer prognosis: The role of nutrition and physical activity.\" Annual Review of Nutrition, 38, 1-13.\u003Cbr>\n    American Society of Clinical Oncology. (2023). \"Cancer Nutrition Guidelines.\"\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.indep-title {\n  font-size: 38px;\n  font-weight: bold;\n  color: #2c4178;\n  background: linear-gradient(90deg,#f8fbff 0%, #eaf0fd 100%);\n  text-align: center;\n  padding: 40px 10px 30px 10px;\n  border-radius: 13px;\n  margin-bottom: 36px;\n  margin-top: 7px;\n  letter-spacing: 2px;\n  font-family: \"Segoe UI\", \"Microsoft YaHei\", Arial, sans-serif;\n  box-shadow: 0 2px 8px rgba(44,65,120,0.09);\n}\n.indep-section {\n  border-radius: 11px;\n  padding: 35px 36px 38px 36px;\n  margin-bottom: 36px;\n  box-shadow: 0 2px 9px rgba(44,65,120,0.10);\n  font-family: \"Segoe UI\", \"Microsoft YaHei\", Arial, sans-serif;\n  background-repeat: no-repeat;\n  background-size: cover;\n  background-blend-mode: lighten;\n}\n.indep-h2 {\n  font-size: 27px;\n  font-weight: 600;\n  color: #3b5d88;\n  margin: 4px 0 23px 0;\n  letter-spacing: 1px;\n  font-family: \"Segoe UI\", \"Microsoft YaHei\", Arial, sans-serif;\n  padding-bottom: 6px;\n}\n.indep-content {\n  font-size: 19px;\n  line-height: 1.83;\n  color: #263650;\n  letter-spacing: 0.2px;\n  font-family: \"Segoe UI\", \"Microsoft YaHei\", Arial, sans-serif;\n  padding-bottom: 3px;\n}\n.indep-content strong {\n  color: #2064a0;\n  font-weight: 550;\n}\n.indep-content ul, .indep-content ol {\n  margin: 18px 0 18px 20px;\n  padding: 0;\n  font-size: 19px;\n}\n.indep-content li {\n  margin-bottom: 9px;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"indep-title\">浸润性导管癌：您需要了解的重要信息\u003C/div>\n\n\u003Cdiv class=\"indep-section\" sty",516,"2025-09-17 15:10:32","浸润性导管癌, 乳腺癌, 癌症症状, 乳腺健康, 癌症治疗, 早期发现, 女性健康, 风险因素","揭示浸润性导管癌的症状、原因及诊断与治疗方案，关注乳腺健康，助您及早发现与应对，提升生活质量。","2025-10-20 16:11:51",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":20,"result":57,"totalSize":21},[],{"code":9,"msg":10,"message":6,"data":59,"success":54},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]